Menu Close

Aesthetic injectable companies. Egypt’s Macro Group Pharmaceuticals covered US$83 million retail portion of IPO

Biorevitalization

THE WHAT? Egypt’s Macro Group Pharmaceuticals has covered a US$83 million retail portion of an initial public offering (IPO) by 102 times at its close this week, according to a report by Reuters. 

THE DETAILS The pharmaceuticals and cosmetics company is selling 45.8 percent of its shares, with 95 percent being offered to investors and 5 percent being listed publicly to retail investors. 

Meso Therapy

THE WHY? Such is the popularity of the stock that private investors had oversubscribed by 1.79 times, while retail investors had offered to buy US$1.35 billion of the 13.23 million retail shares at £4.85 each, according to stock exchange data. 

This gives an implied company valuation of £2.8 billion. 

Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.

Key aspects of aesthetic injectable companies include:

  • Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.

  • Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.

  • Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.

  • Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.

  • Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.

  Aesthetic injectable companies. L’Oréal receives Moody’s first-time long-term rating of Aa